Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
China · Delayed Price · Currency is CNY 99.47
+1.87 (1.92%)
Sep 30, 2026, 3:00 PM CST
SHA:688131 Market Cap
SHA:688131 has a market cap or net worth of 21.21 billion as of October 7, 2026. That makes SHA:688131 the world's 5,055th most valuable company and 823rd in China. Its market cap has increased by 28.77% in one year.
Market Cap
21.21B
Enterprise Value
22.03B
Revenue
3.21B
Global Rank
Country Rank
#823 China
PE Ratio
81.54
ChartMarket Cap Chart
Since June 8, 2021, SHA:688131's market cap has decreased from 23.30B to 21.21B, a decrease of -8.97%. That is a compound annual growth rate of -1.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 21.21B | 38.73% |
| Dec 31, 2025 | 15.29B | 103.03% |
| Dec 31, 2024 | 7.53B | -3.82% |
| Dec 29, 2023 | 7.83B | -32.18% |
| Dec 30, 2022 | 11.54B | -37.56% |
| Dec 31, 2021 | 18.49B | -20.66% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 23.62B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.54B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 23.09B |
| Walvax Biotechnology | 22.76B |
| Betta Pharmaceuticals | 21.24B |
| Hybio Pharmaceutical | 21.13B |
| Tasly Pharmaceutical Group | 20.92B |
| Guangdong Zhongsheng Pharmaceutical | 20.42B |